STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds S Nabhani, C Schipp, H Miskin, C Levin, S Postovsky, T Dujovny, A Koren, ... Clinical Immunology 181, 32-42, 2017 | 62 | 2017 |
EBV negative lymphoma and autoimmune lymphoproliferative syndrome like phenotype extend the clinical spectrum of primary immunodeficiency caused by STK4 deficiency C Schipp, D Schlütermann, A Hönscheid, S Nabhani, J Höll, PT Oommen, ... Frontiers in Immunology 9, 2400, 2018 | 49 | 2018 |
Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans C Schipp, S Nabhani, K Bienemann, N Simanovsky, S Kfir-Erenfeld, ... Haematologica 101 (10), e392, 2016 | 49 | 2016 |
Hematopoietic stem cell transplantation in an infant with immunodeficiency, centromeric instability, and facial anomaly syndrome KL Gössling, C Schipp, U Fischer, F Babor, G Koch, FR Schuster, ... Frontiers in immunology 8, 773, 2017 | 20 | 2017 |
2% of Healthy Newborns Reveal ETV6-RUNX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL) D Schaefer, M Olsen, U Lausten-Thomsen, C Schipp, M Stanulla, ... Blood 128 (22), 4082, 2016 | 1 | 2016 |
Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway LM Kuhn, C Schipp, D Hein, B Killing, N Qin, VH Jepsen, H Ahlert, J Bartl, ... Blood 134, 4651, 2019 | | 2019 |
The Landscape of Circular RNAs in Drug Resistant TCF3-Rearranged Childhood Leukemia C Chen, D Picard, N Qin, C Schipp, M Gombert, S Ginzel, J Hu, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 1432 …, 2017 | | 2017 |
Mutations of NKFB1 and STAT3 in the pathogenesis of autoimmune lymphoproliferative syndrome like disorders C Schipp Heinrich-Heine-Universität Düsseldorf, 2017 | | 2017 |
Mutationen von STAT3 und NFKB1 in der Pathogenese von Autoimmun-Lymphoproliferativen Syndrom ähnlichen Erkrankungen C Schipp | | 2017 |
Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing C Schipp, A Borkhardt, P Stepensky, U Fischer Blood, The Journal of the American Society of Hematology 128 (22), 3706-3706, 2016 | | 2016 |
STAT3 gain-of-function mutations cause autoimmune lymphoproliferative syndrome like disease by dysregulating expression of fas and BCL2 proteins and can be therapeutically … S Nabhani, H Miskin, C Schipp, C Levin, T Dujovny, A Koren, D Harlev, ... EHA21, Copenhagen, Denmark, June 09-12, 2016, 2016 | | 2016 |
ANALYSIS OF MOLECULAR MECHANISMS OF DOMINANT-INTERFERING FAS MUTATIONS D Schaefer, S Nabhani, C Schipp, L Loizou, PT Oommen, HJ Laws, ... HAEMATOLOGICA 101, 302-302, 2016 | | 2016 |
Activating Mutation of STAT3 Protects Lymphocytes from Apoptosis and Leads to a Clinical Phenotype Resembling the Autoimmune Lymphoproliferative Syndrome S Nabhani, H Miskin, C Schipp, D Harlev, S Revel-Vilk, M Gombert, ... Blood 126 (23), 2218, 2015 | | 2015 |